Good distribution practices ensure maintaining product safety and quality during distribution across the supply chain and this practice is of significant importance for the pharmaceutical industry. Good Distribution Practices (GDP) Compliance report for Pharmaceutical Industry demonstrates Quality commitment & sound practices in the entire pharmaceutical distribution supply chain.
Managing quality of medicines during distribution is a challenging operation. The challenges of the pharmaceutical products supply chain is and due to its specified shelf life and storage conditions. The various dosage forms (eg tablets, syrups, injectables etc.) are to be transported and stored at different environmental conditions hence all medicines cannot be handled with a general rule. viz the requirement of handling tablets, syrups and injectables shall widely vary.
Ensures principles of GDP are applied throughout the supply chain.
Maintains product integrity and patient safety.
Helps achieve consistency.
Reduces the risk of falsified medicines entering the supply chain.
Reduces distribution complaints.
Improves customer confidence.
Reduces expensive mistakes.
Acceptance of Proposal and Contract Signature
Gap Analysis (Optional): Pre-assessment of your system to evaluate the current state against requirements of the standard.
Audit Stage 1: Initial Visit to verify the establishment and implementation of the Management System; 4- Audit Stage 2: Certification audit (certificate issued after successful certification audit)
Decision making Stage and Certification Issuance
1st Surveillance Audits (After 1 year of registration) to evaluate the maintenance and the Continual Improvement of Management System
2nd Surveillance Audits (After 2 year of registration) to evaluate the maintenance and the Continual Improvement of Management System
Re-Certification (after 3 Years of initial registration), Signing an other contract
